9 April 2026 News

Health, Lyme disease, Research, Ticks, Blood pressure were the most important topics in the news of the Thursday 9 April 2026, but also: Food, Salt.

Find all the publications

Consult all of 24matins.uk articles by selecting the date of your choice.

News from 09/04/2026

Breakthrough in Tick Research Offers New Hope for Lyme Disease

A significant scientific breakthrough in tick research is generating renewed optimism in the ongoing battle against Lyme disease. This development...

Intellectual Property Pledge Financing Service Market Analysis Report 2026-2032: $915.12 Mn Opportunities in Tech, Life Sciences, Media, and Manufacturing

Dublin, April 09, 2026 (GLOBE NEWSWIRE) -- The "Intellectual Property Pledge Financing Service Market - Global Forecast 2026-2032" has been...

Virtune AB (Publ) (“Virtune”) has completed the monthly rebalancing for March 2026 of its Virtune Crypto Top 10 Index ETP – the first crypto index ETP in the Nordics

Stockholm, 9 April 2026 - Virtune today announces the completion of the monthly rebalancing for the Virtune Crypto Top 10 Index ETP, listed...

Himalayan Salt: Effects on Blood Pressure and Health

Himalayan salt, often praised for its mineral content and rosy hue, has become a popular alternative to regular table salt. However, questions...

Bitwise launches Hyperliquid Staking ETP

Product aims to provide exposure to HYPE, the native token of Hyperliquid blockchain platform, including potential staking rewards Hyperliquid...

Coop Pank launches a share buyback programme

On the basis of the resolution of the general meeting of Coop Pank AS (hereinafter Coop Pank) adopted on 8 April 2026 and the resolution of...

Sauna bathing may boost immune responses

Kuopio, Finland., April 09, 2026 (GLOBE NEWSWIRE) -- Sauna bathing releases white blood cells into the bloodstream, a new study from Finland...

Nxera Pharma Achieves Second Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases

Tokyo, Japan and Cambridge, UK, 09 April 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it...